News Why relying on AI outcome models may not be a good idea The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
Digital Alongside diagnosis: AI’s role in shaping health transformat... Humans are about to go hybrid – in fact, our race is undergoing its own digital transformation.
R&D Defining innovation: The battle for clarity, access, and sta... The pharmaceutical industry often claims its medicines as highly innovative and expects to be compensated accordingly.
News Third death reported with a Sarepta gene therapy A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face